Also
- Share via
* Clorox Co. confirmed that it expects strong profit growth of about 66% in its fiscal fourth quarter, based on strong sales growth in North America. Oakland-based Clorox expects earnings of 60 cents to 62 cents a share for the quarter, compared with analysts’ average forecast of 61 cents. Sales should rise by 5% to 6%, the company said.
* Osteometer MediTech Inc. said it received approval from the Food and Drug Administration to sell DexaCare, a tabletop bone-density meter designed for use by physicians. The company, a unit of Hawthorne-based OSI Systems Inc., said it expects to begin shipping the device in August for a price of about $25,000 to $30,000. It did not give an estimate of sales.
* Faucet maker Masco Corp. said it bought five window and plumbing parts makers, including closely held Newport Brass, a Santa Ana maker of plumbing products and bath accessories, for about $220 million in cash and stock. The other companies are based in Britain.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
